Novavax (NVAX) News Today $6.69 +0.27 (+4.21%) As of 03:52 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Barclays PLCBarclays PLC trimmed its position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 41.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 413,467 shares of the biopharmaceutical company's stock after selling 296,11April 30 at 3:49 AM | marketbeat.comNvidia & chip stocks falling, Novavax vaccine, Zscaler upgradeApril 30 at 3:31 AM | uk.finance.yahoo.comTrump’s FDA wants a new trial for Novavax’s COVID-19 shot, sparking uncertainty about updates to other vaccinesApril 29 at 8:27 AM | fortune.comNovavax Appoints Charles Newton to Board of DirectorsApril 29 at 8:00 AM | prnewswire.comTrump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval TimelineApril 29 at 4:24 AM | benzinga.comNovavax, Inc. (NASDAQ:NVAX) Receives Average Recommendation of "Hold" from AnalystsShares of Novavax, Inc. (NASDAQ:NVAX - Get Free Report) have received a consensus rating of "Hold" from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigApril 29 at 2:21 AM | marketbeat.comFDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shotsApril 28 at 5:12 PM | financialpost.comFDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shotsThere’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from NovavaxApril 28 at 5:00 PM | marketbeat.com‘Regulatory Headwinds Set to Bite,’ Says Top Analyst on Novavax Stock (NVAX)April 28 at 7:19 AM | tipranks.comNovavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval HopesApril 28 at 4:12 AM | msn.comBank of Montreal Can Trims Holdings in Novavax, Inc. (NASDAQ:NVAX)Bank of Montreal Can reduced its stake in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 99.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,315 shares of the biopharmaceutical company's stock after selling 2,44April 28 at 3:32 AM | marketbeat.comNovavax asked by FDA to complete additional COVID trial, WSJ saysApril 27 at 4:56 PM | markets.businessinsider.comNovavax shares fall following WSJ report on FDA trial requestApril 26, 2025 | za.investing.comNovavax (NasdaqGS:NVAX) Announces Positive SHIELD-Utah Study ResultsApril 26, 2025 | finance.yahoo.comNovavax down 10% after WSJ report on FDA request for additional vaccine trialApril 26, 2025 | markets.businessinsider.comNovavax asked for new Covid-19 vaccine trial by FDA, WSJ reportsApril 26, 2025 | markets.businessinsider.comUS FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reportsApril 26, 2025 | msn.comBenzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce BackApril 26, 2025 | benzinga.comDauntless Investment Group LLC Takes Position in Novavax, Inc. (NASDAQ:NVAX)Dauntless Investment Group LLC bought a new position in Novavax, Inc. (NASDAQ:NVAX - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 86,861 shares of the biopharmaceutical company's stock, valued at approximately $698,000. NovavaApril 26, 2025 | marketbeat.comNovavax (NVAX) Shares Surge After Positive SHIELD-Utah Study ResultsApril 26, 2025 | gurufocus.comNovavax (NVAX) Faces FDA Hurdle for COVID-19 Vaccine ApprovalApril 25, 2025 | gurufocus.comFDA Requests New Novavax (NVAX) Covid-19 Vaccine Trial, Testing Company's Resources | NVAX ...April 25, 2025 | gurufocus.comFDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reportsApril 25, 2025 | reuters.comFDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 ShotApril 25, 2025 | wsj.comCanada Pension Plan Investment Board Acquires 71,500 Shares of Novavax, Inc. (NASDAQ:NVAX)Canada Pension Plan Investment Board boosted its stake in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 23.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 379,300 shares of the biopharmaceutical company's stock after buying an addiApril 25, 2025 | marketbeat.comAs FDA delays Novavax' COVID vaccine approval, patients fight backApril 24, 2025 | msn.comInsight: As FDA delays Novavax' COVID vaccine approval, patients fight backApril 24, 2025 | reuters.comNovavax (NVAX) Rises Amid FDA Data Request for COVID-19 VaccineApril 24, 2025 | gurufocus.comNovavax has improved clarity on path forward for Nuvaxovid, says BofAApril 23, 2025 | markets.businessinsider.comNovavax says received formal PMC request from FDA related to COVID vaccineApril 23, 2025 | markets.businessinsider.comNovavax shares soar after FDA request raises hope for COVID vaccine approvalApril 23, 2025 | msn.comNovavax's COVID-19 Vaccine Nears FDA Full Approval, Stock JumpsApril 23, 2025 | benzinga.comNovavax's COVID-19 Vaccine Nears FDA Full Approval, Stock JumpsApril 23, 2025 | benzinga.comFDA asks Novavax for post-approval data on COVID vaccine, raising hopes for green lightApril 23, 2025 | msn.comNovavax up on FDA's request for additional COVID-19 shot dataApril 23, 2025 | seekingalpha.comNovavax's stock surges on 'good news' from Food and Drug AdministrationApril 23, 2025 | bizjournals.comNovavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment WaversApril 23, 2025 | msn.comNovavax (NVAX) Awaits FDA Approval Following Additional Data Request | NVAX Stock NewsApril 23, 2025 | gurufocus.comNovavax (NVAX) Sees Stock Surge Following FDA Communication on Nuvaxovid | NVAX Stock NewsApril 23, 2025 | gurufocus.comNovavax shares jump as FDA signals path to COVID vaccine approvalApril 23, 2025 | proactiveinvestors.comNovavax says its COVID-19 shot is on track for full FDA approval after delayApril 23, 2025 | financialpost.comNovavax says its COVID-19 shot is on track for full FDA approval after delayApril 23, 2025 | financialpost.comNovavax stock jumps on positive FDA discussionsApril 23, 2025 | investing.comNovavax jumps after FDA asks for more data on its Covid vaccineApril 23, 2025 | msn.comNovavax up on FDA's request for additional data for COVID-19 shotApril 23, 2025 | msn.comNovavax says its COVID-19 shot is on track for full FDA approval after delayNovavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug AdministrationApril 23, 2025 | marketbeat.comNovavax’s Biologics License Application Nears ApprovalApril 23, 2025 | tipranks.comFDA asks Novavax for commitment on post-approval studies for COVID vaccineApril 23, 2025 | reuters.comNovavax (NVAX) Shows Promising Vaccine Results Amid Market StabilityApril 21, 2025 | gurufocus.comNovavax, Inc. (NASDAQ:NVAX) Shares Bought by Geode Capital Management LLCGeode Capital Management LLC boosted its stake in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 4.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 3,657,695 shares of the biopharmaceutical company's stock after acquiring an additional 155,206 sApril 20, 2025 | marketbeat.com Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.530.85▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼3411▲NVAX Articles Average Week Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amicus Therapeutics News Ligand Pharmaceuticals News BioCryst Pharmaceuticals News MannKind News Celldex Therapeutics News Dynavax Technologies News Innoviva News OPKO Health News Geron News Myriad Genetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVAX Stock Free NVAX Stock Alerts